Studies related to HbA1c and Berberine

Berberine In The Treatment Of Type 2 Diabetes Mellitus: A Systemic Review And Meta-analysis

Effect Decrease
Trial Design Meta analysis
Trial Length n/a
Number of Subjects 1068
Sex n/a
Notes for this study:
In diabetic patients, Berberine at 0.5-1.5g daily for an average period of 12 weeks was associated with minor to moderate improvements on all measured glucose and lipid parameters; rivalling oral hypoglycemics in potency

Full details on all 3 studies are available to Examine Members. Try out the Examine Membership with a 14-day free trial.

Already a Member? Log in now to access.